These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 28857991

  • 1. Spontaneous Healing of Clodronate-Related Osteonecrosis of the Jaw.
    Nastro Siniscalchi E, Allegra A, De Ponte FS, Oteri G, Cervino G, Lauritano F, Musolino C, Cicciù M.
    J Craniofac Surg; 2017 Oct; 28(7):e687-e689. PubMed ID: 28857991
    [Abstract] [Full Text] [Related]

  • 2. Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.
    Crépin S, Laroche ML, Sarry B, Merle L.
    Eur J Clin Pharmacol; 2010 Jun; 66(6):547-54. PubMed ID: 20437036
    [Abstract] [Full Text] [Related]

  • 3. Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.
    Montazeri AH, Erskine JG, McQuaker IG.
    Eur J Haematol; 2007 Jul; 79(1):69-71. PubMed ID: 17598839
    [Abstract] [Full Text] [Related]

  • 4. Treatment of Osteonecrosis of the Jaw.
    Yamachika E, Matsubara M, Ikeda A, Matsumura T, Moritani N, Iida S.
    J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous Healing of Mandibular Noncontinuous Defect Caused by Medication-Related Osteonecrosis of the Jaw.
    Yazan M, Atil F, Kocyigit ID, Tekin U, Tuz HH, Misirlioglu M.
    J Craniofac Surg; 2016 Jun; 27(4):e390-2. PubMed ID: 27244207
    [Abstract] [Full Text] [Related]

  • 6. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
    Aljohani S, Fliefel R, Ihbe J, Kühnisch J, Ehrenfeld M, Otto S.
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
    [Abstract] [Full Text] [Related]

  • 7. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
    Lopes RN, Rabelo GD, Rocha AC, Carvalho PA, Alves FA.
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
    [Abstract] [Full Text] [Related]

  • 8. Surgical treatment of stage 2 medication-related osteonecrosis of the jaw compared to osteomyelitis.
    Kang SH, Won YJ, Kim MK.
    Cranio; 2018 Nov; 36(6):373-380. PubMed ID: 28854059
    [Abstract] [Full Text] [Related]

  • 9. Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: a pooled case report analysis.
    Hinson AM, Siegel ER, Stack BC.
    J Oral Maxillofac Surg; 2015 Jan; 73(1):53-62. PubMed ID: 25511956
    [Abstract] [Full Text] [Related]

  • 10. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G, Manfredi M, Giovannacci I, Mergoni G, Sarraj A, Mureddu M, Giunta G, Bonanini M, Meleti M, Vescovi P.
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [Abstract] [Full Text] [Related]

  • 11. Safety of I.V. Nonnitrogen bisphosphonates on the occurrence of osteonecrosis of the jaw: long-term follow-up on prostate cancer patients.
    Rodrigues P, Hering F, Imperio M.
    Clin Genitourin Cancer; 2015 Jun; 13(3):199-203. PubMed ID: 25475039
    [Abstract] [Full Text] [Related]

  • 12. Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL, Kohn N.
    J Oral Maxillofac Surg; 2015 Dec; 73(12 Suppl):S94-S100. PubMed ID: 26608159
    [Abstract] [Full Text] [Related]

  • 13. The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series.
    Fernando de Almeida Barros Mourão C, Calasans-Maia MD, Del Fabbro M, Le Drapper Vieira F, Coutinho de Mello Machado R, Capella R, Miron RJ, Gomes Alves G.
    J Stomatol Oral Maxillofac Surg; 2020 Feb; 121(1):84-89. PubMed ID: 30794883
    [Abstract] [Full Text] [Related]

  • 14. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B, Zajko J, Hirjak D, Vanko L, Kupcova I, Jurkemik J, Gengelova P, Mikuskova K, Halmova K, Riznic M, Czako L.
    Bratisl Lek Listy; 2017 Feb; 118(12):724-731. PubMed ID: 29322803
    [Abstract] [Full Text] [Related]

  • 15. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J, Peydró A, Calvo J, Leopoldo M, Jiménez Y, Bagan L.
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [Abstract] [Full Text] [Related]

  • 16. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I, Meleti M, Manfredi M, Mortellaro C, Greco Lucchina A, Bonanini M, Vescovi P.
    J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis.
    Hayashida S, Soutome S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Kojima Y, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Umeda M.
    J Bone Miner Res; 2017 Oct; 32(10):2022-2029. PubMed ID: 28585700
    [Abstract] [Full Text] [Related]

  • 18. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
    Gross C, Weber M, Creutzburg K, Möbius P, Preidl R, Amann K, Wehrhan F.
    J Transl Med; 2017 Jun 06; 15(1):128. PubMed ID: 28587628
    [Abstract] [Full Text] [Related]

  • 19. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P, Engelhardt M, Schmelzeisen R, Voss P.
    Dtsch Arztebl Int; 2017 Feb 03; 114(5):63-69. PubMed ID: 28241916
    [Abstract] [Full Text] [Related]

  • 20. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
    Otto S, Ristow O, Pache C, Troeltzsch M, Fliefel R, Ehrenfeld M, Pautke C.
    J Craniomaxillofac Surg; 2016 Aug 03; 44(8):1073-80. PubMed ID: 27263757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.